RecallRadar

FDA Drug recall D-1086-2015

Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Ther…

On 2015-06-03 the FDA classified a Class II recall of Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Ther… by Noven Pharmaceuticals, citing defective Delivery System: One lot exceeded the mechanical peel specification.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1086-2015
ClassificationClass II
Statusterminated
Initiated2015-01-12
Published2015-06-03
Last updated2026-09-13 11:51 UTC
CompanyNoven Pharmaceuticals
DistributionUS

Product

Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Therapeutics LLC, Miami, FL 33186, by Noven Pharmaceuticals Inc., Miami, FL 33186, NDC # 68968-5555-3

Reason

Defective Delivery System: One lot exceeded the mechanical peel specification

Identifiers

ndc68968-5552-3
ndc68968-5553-3
ndc68968-5554-3
ndc68968-5555-3
code_infoLot # 73346, Exp 03/2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1086-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.